Gene · 406949
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches? | Cancers (Basel) | 2023 | 38067261 | PubTator, text mining | PubMed |
| Integrative analysis of long noncoding RNAs dysregulation and synapse-associated ceRNA regulatory axes in autism. | Transl Psychiatry | 2023 | 38057311 | PubTator, text mining | PubMed |
| Identifying potential pathogenesis and immune infiltration in diabetic foot ulcers using bioinformatics and in vitro analyses. | BMC Med Genomics | 2023 | 38041124 | PubTator, text mining | PubMed |
| A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease. | Exp Hematol Oncol | 2023 | 38041102 | PubTator, text mining | PubMed |
| A deep learning model predicts the presence of diverse cancer types using circulating tumor cells. | Sci Rep | 2023 | 38036622 | PubTator, text mining | PubMed |
| Computational study of the motor neuron protein KIF5A to identify nsSNPs, bioactive compounds, and its key regulators. | Front Genet | 2023 | 38028604 | PubTator, text mining | PubMed |
| Long non-coding RNA PVT1 (PVT1) affects the expression of CCND1 and promotes doxorubicin resistance in osteosarcoma cells. | J Bone Oncol | 2023 | 38021073 | PubTator, text mining | PubMed |
| Therapeutic Potential of P110 Peptide: New Insights into Treatment of Alzheimer's Disease. | Life (Basel) | 2023 | 38004296 | PubTator, text mining | PubMed |
| Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease. | Int J Mol Sci | 2023 | 38003448 | PubTator, text mining | PubMed |
| Strain Variation Can Significantly Modulate the miRNA Response to Zika Virus Infection. | Int J Mol Sci | 2023 | 38003407 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Human Cancer and Other Diseases: Overview of the Diagnostic Potential. | Int J Mol Sci | 2023 | 38003403 | PubTator, text mining | PubMed |
| Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in Cancer. | Genes (Basel) | 2023 | 38003016 | PubTator, text mining | PubMed |
| The Pathological Role of miRNAs in Endometriosis. | Biomedicines | 2023 | 38002087 | PubTator, text mining | PubMed |
Integrated Network Analysis of microRNAs, mRNAs, and Proteins Reveals the Regulatory Interaction between hsa-mir-200b and CFL2 Associated with Advanced Stage and Poor Prognosis in Patients with Intestinal Gastric Cancer. | Cancers (Basel) | 2023 | 38001634 | PubTator, text mining | PubMed |
| Research progress on the effects of adverse exposure during pregnancy on skeletal muscle function in the offspring. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 37986679 | PubTator, text mining | PubMed |
| Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. | Cancer Cell Int | 2023 | 37986065 | PubTator, text mining | PubMed |
| Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy. | Cell Death Discov | 2023 | 37978169 | PubTator, text mining | PubMed |
| Insights into the radiotherapy-induced deferentially expressed RNAs in colorectal cancer management. | Iran J Basic Med Sci | 2023 | 37970448 | PubTator, text mining | PubMed |
| Biological and clinical significance of the glypican-3 gene in human lung adenocarcinoma: An in silico analysis. | Medicine (Baltimore) | 2023 | 37960765 | PubTator, text mining | PubMed |
| Adding Value to Liquid Biopsy for Brain Tumors: The Role of Imaging. | Cancers (Basel) | 2023 | 37958372 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406949/papers?page=8